These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 12943519)

  • 1. IGF-I and IGF-binding protein-3 measurements on filter paper blood spots in children and adolescents on GH treatment: use in monitoring and as markers of growth performance.
    Das U; Whatmore AJ; Khosravi J; Wales JK; Butler G; Kibirige MS; Diamandi A; Jones J; Patel L; Hall CM; Price DA; Clayton PE
    Eur J Endocrinol; 2003 Sep; 149(3):179-85. PubMed ID: 12943519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy.
    Ballerini MG; Braslavsky D; Scaglia PA; Keselman A; Rodríguez ME; Martínez A; Freire AV; Domené HM; Jasper HG; Bergadá I; Ropelato MG
    Horm Res Paediatr; 2017; 88(5):354-363. PubMed ID: 28926833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of insulin-like binding protein-2 in prepubertal short children and its diagnostic value in the evaluation of growth hormone deficiency.
    van Doorn J; Ringeling AM; Rikken B; van Buul-Offers SC
    Horm Res; 2001; 55(3):147-54. PubMed ID: 11549877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of IGF-I, IGFBP-3, and IGFBP-2 measurements during GH treatment of GH-deficient and non-GH-deficient children and adolescents.
    Ranke MB; Schweizer R; Elmlinger MW; Weber K; Binder G; Schwarze CP; Wollmann HA
    Horm Res; 2001; 55(3):115-24. PubMed ID: 11549872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bayesian Approach to Diagnose Growth Hormone Deficiency in Children: Insulin-Like Growth Factor Type 1 Is Valuable for Screening and IGF-Binding Protein Type 3 for Confirmation.
    Inoue-Lima TH; Vasques GA; Nakaguma M; Brito LP; Mendonça BB; Arnhold IJP; Jorge AAL
    Horm Res Paediatr; 2020; 93(3):197-205. PubMed ID: 32799208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GH response to provocation and circulating IGF-I and IGF-binding protein-3 concentrations, the IGF-I generation test and clinical response to GH therapy in children with beta-thalassaemia.
    Soliman AT; El Banna N; Ansari BM
    Eur J Endocrinol; 1998 Apr; 138(4):394-400. PubMed ID: 9578506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of insulin-like growth factor (IGF)-I and IGF binding protein-3 generation test in short stature.
    Darendeliler F; Ocal C; Baş F
    J Pediatr Endocrinol Metab; 2005 May; 18(5):443-52. PubMed ID: 15921173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3.
    Juul A; Skakkebaek NE
    J Pediatr; 1997 Feb; 130(2):197-204. PubMed ID: 9042120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone therapy does not alter the insulin-like growth factor-I/insulin-like growth factor binding protein-3 molar ratio in growth hormone-deficient children.
    Scirè G; Del Bianco C; Spadoni GL; Cianfarani S
    J Endocrinol Invest; 2008 Feb; 31(2):153-8. PubMed ID: 18362507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of diagnostic accuracy of insulin-like growth factor (IGF)-I and IGF-binding protein-3 in growth hormone-deficient children and adults using ROC plot analysis.
    Boquete HR; Sobrado PG; Fideleff HL; Sequera AM; Giaccio AV; Suárez MG; Ruibal GF; Miras M
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4702-8. PubMed ID: 14557444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen priming effect on growth hormone (GH) provocative test: a useful tool for the diagnosis of GH deficiency.
    Martínez AS; Domené HM; Ropelato MG; Jasper HG; Pennisi PA; Escobar ME; Heinrich JJ
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4168-72. PubMed ID: 11095449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of insulin like growth factor (IGF)-1 and IGF-binding protein-3 in diagnosis of Growth Hormone Deficiency in short stature children.
    Haghshenas Z; Sotoudeh K; Karamifar H; Karamizadeh Z; Amirhakimi G
    Indian J Pediatr; 2009 Jul; 76(7):699-703. PubMed ID: 19381505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) concentrations compared to stimulated growth hormone (GH) in the evaluation of children treated for malignancy.
    Cicognani A; Cacciari E; Pession A; Pasini A; De Iasio R; Gennari M; Alvisi P; Pirazzoli P
    J Pediatr Endocrinol Metab; 1999; 12(5):629-38. PubMed ID: 10703534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.